“…Most studies analyzed 25(OH)D by chemiluminescent immunoassay. Nineteen articles compared 25(OH)D levels between CD patients and control groups [8, 14, 17-20, 22, 25-28, 30-33, 35, 36, 42, 43] , of which eleven found lower 25(OH)D levels in CD patients compared with controls [17,18,20,25,28,31,33,35,36,42,43] . Eleven articles reported the numbers of patients and controls with VitD de ciency [8,14,18,22,25,26,28,30,33,35,43] , and eight showed that 25(OH)D de ciency was more prevalent in CD patients [8,18,25,26,28,33,35,43] .…”